WMU-33315-37984
2 vaccinations
1 coded response
22 check-ins
1 free-text entry
0 call cases
- Sex
- Female
- Age at first dose
- 31-35
- ZIP prefix
- 300 / GA
- Registered
- 2021-08-19
- Relationship
- Self
- Race
- White
- Ethnicity
- Hispanic or Latino
Timeline
-
2021-08-19
Registered in v-safe
-
2021-08-19
Dose 1 — Pfizer-BioNTech
- 2021-08-19
- 2021-08-20
- 2021-08-21
- 2021-08-22
- 2021-08-23
- 2021-08-25
- 2021-08-26
- 2021-09-02
-
2021-09-08
Dose 2 — Pfizer-BioNTech
- 2021-09-08
-
2021-09-09
Health check-in — days 1–6 daily, dose 2Feeling: Poor · Site: Pain · Fever · Headache, Muscle or body aches, Fatigue or tiredness · Be unable to work or attend school, Be unable to do your normal daily activitiesAdult check-in
- 2021-09-10
- 2021-09-11
- 2021-09-12
- 2021-09-13
- 2021-09-14
- 2021-09-15
- 2021-09-22
- 2021-09-29
- 2021-10-10
- 2021-10-13
- 2021-10-20
-
2021-12-08
Survey response — 3 months, dose 2MedDRA: Nasal congestion, Oropharyngeal pain — Feeling: GoodFree text: Sore throat, nasal congestionMedDRA releases: 2024-11 · check-in free text available
Vaccinations
| Dose | Date | Manufacturer | Co-administered |
|---|---|---|---|
| 1 | 2021-08-19 | Pfizer-BioNTech | No |
| 2 | 2021-09-08 | Pfizer-BioNTech | No |
Free text
Release 10 — 3 months, dose 2
Symptoms: Sore throat, nasal congestion
Each entry is dated by the survey it was written in (the CDC re-sent the releases with survey dates in 2025); click a date to see that survey response. The CDC cut some text off at about 250 characters: symptoms in every release, and the other two fields in releases 9-12. Those entries are marked "cut off by CDC".
MedDRA terms by release
| Field | Preferred term | 2021-09 | 2023-04 | 2024-11 |
|---|---|---|---|---|
| SD | Nasal congestion | · | · | ✓ |
| SD | Oropharyngeal pain | · | · | ✓ |
✓ active code · ○ coded but marked inactive · blank = not in that release